Cipla
Amit Jaiswal serves as the Global Head of Internal Audit at Cipla, bringing a wealth of expertise in the field of internal auditing. Prior to this role, Amit Jaiswal worked at M/s Suresh Surana & Associates, where responsibilities included internal audit functions. With a strong background in auditing, Amit Jaiswal is well-equipped to oversee and enhance internal audit processes on a global scale.
This person is not in any teams
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.